Khiron Life Sciences Corp. To Present At The Q1 Virtual Investor Summit
11 Março 2021 - 10:30AM
via InvestorWire - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX:
KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader
with core operations in Latin America and Europe, today announced
that Alvaro Torres, CEO, will be attending the Q1 Virtual Investor
Summit.
Event |
Q1 Investor Summit |
Date |
March 23-25th, 2021 |
Presentation |
March 24th @ 1:00PM ET |
Location |
https://zoom.us/webinar/register/WN_t9RgOzoRRWWAbgaCyaYTaQ |
About The Investor SummitThe Investor Summit
(formerly MicroCap Conference) is an exclusive, independent
conference dedicated to connecting smallcap and microcap companies
with qualified investors. The Q1 Investor Summit will take place
virtually, featuring 100 companies and over 300 institutional and
retail investors.
To request complimentary investor registration: please visit our
website at www.investorsummitgroup.com
Contact: Brittney Blocker at
brittney@investorsummitgroup.com
ABOUT Khiron Life Sciences
Corp
Khiron is a vertically integrated medical and
CPG cannabis company with core operations in Latin America, and
operational activity in Europe and North America. Khiron is the
leading medical cannabis provider in Colombia and the first company
licensed in Colombia for the cultivation, production, domestic
distribution and sales, and international export of both low and
high THC medical cannabis products. The Company has filled medical
cannabis prescriptions in Colombia, Peru and the UK, and is
positioned to commence sales of medical cannabis in Germany and
Brazil in early 2021.
Leveraging wholly-owned medical clinics and
proprietary telemedicine platforms, Khiron combines a
patient-oriented approach, physician education programs, scientific
expertise, product innovation, and agricultural infrastructure to
drive prescriptions and brand loyalty. Its Wellbeing unit launched
the first branded CBD skincare brand in Colombia, with Kuida™ now
marketed in multiple jurisdictions in Latin America, the US and UK.
The Company is led by Co-founder and Chief Executive Officer,
Alvaro Torres, together with an experienced and diverse executive
team and Board of Directors.
Wire Service Contact:
InvestorWire (IW)
Los Angeles, California
www.InvestorWire.com
212.418.1217 Office
Editor@InvestorWire.com
Khiron Life Sciences (TSXV:KHRN)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Khiron Life Sciences (TSXV:KHRN)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025
Notícias em tempo-real sobre Khiron Life Sciences Corp da TSX Venture Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de